AP- Pfizer is set to ask U.S. regulators to allow emergency use of its COVID-19 vaccine, starting a process that could bring first shots as early as next month. Friday's step comes days after Pfizer and its German partner BioNTech announced its vaccine appears 95% protective in a large but not yet finished study. Over the next few weeks, the Food and Drug Administration and its scientific advisers will have to decide if there's really enough evidence to allow emergency vaccinations. If so, first supplies will be scarce and rationed. Experts warn it likely will be spring before there's enough for everyone.
Photo courtesy of AP Photo/Mark Lennihan, File
Pfizer is set to ask U.S. regulators to allow emergency use of its COVID-19 vaccine, starting a process that could bring first shots as early as next month.
Posted: Nov 20, 2020 11:45 AM
- Pfizer Seeking Emergency Use of its COVID-19 Vaccine in US
- United Airlines To Fly Pfizer COVID-19 Vaccine
- UK Authorizes Pfizer Coronavirus Vaccine for Emergency Use
- U.K. Becomes First Country to Approve Pfizer-BioNTech Covid-19 Vaccine
- COVID-19 Vaccine is Looking 90% Effective According to Pfizer
- FDA approves Pfizer COVID-19 vaccine for 12- to 15-year olds
- Pfizer Says Vaccine Can Work Against Variants
- FDA Authorizes Pfizer's Covid Vaccine for Emergency Use, Major First Step Toward Bringing Pandemic to End
- FDA Advisory Panel Votes to Recommend Emergency use of Pfizer Vaccine, Probably Leading to Final Approval this Week
- U.K. Probing if Allergic Reactions Linked to Pfizer Vaccine
Scroll for more content...